About Wouter Joustra
Wouter Joustra is a director at Navigator Medicines.
Wouter Joustra first appears on SEC filings in 2024.
Experience
This experience comes from Wouter Joustra's profile and from SEC filings. For roles taken from filings, the years are when the filings name Wouter Joustra in the role, so the role may have started earlier or lasted longer.
VB
Vor Bio Current
Member Board of Directors (NASDAQ: VOR)
2025 – Present
VB
Verdiva Bio Current
Member Board of Directors & Founding Investor
2025 – Present
Navigator Medicines, Inc. Current
Member Board of Directors
2024 – Present · San Mateo, CA
Develops antibody treatments for people with inflammatory and autoimmune diseases.
BT
Beacon Therapeutics Current
Member Board of Directors
2024 – Present
EN
enGene Current
Member Board of Directors (NASDAQ: ENGN)
2024 – Present
VE
VectorY Current
Member Board of Directors
2023 – Present
NC
NewAmsterdam Pharma Corporation Current
Member Board of Directors (NASDAQ: NAMS)
2021 – Present
FO
Forbion Current
General Partner
2019 – Present
AB
Aiolos Bio
Board Member & Founding Investor - Sold to GSK for up to $1.4bn
2023 – 2024
VA
VectivBio AG
Board Member (NASDAQ: VECT) - Sold to Ironwood for $1.2bn
2022 – 2023
GT
Gyroscope Therapeutics
Board Member - Sold to Novartis for up to $1.5bn
2021 – 2022
VB
Van Lanschot Kempen Investment Banking
Executive Boardmember Life Sciences Franchise
2017 – 2019
KC
Kempen & Co
Senior Life Sciences Trader
2013 – 2019
DD
Da Vinci Derivatives
Derivatives Trader
2016
Key Colleagues at Startups
The people Wouter Joustra works with at each company, as listed on that company's latest Form D.
Navigator Medicines, Inc. · Form D, Sep 25, 2026
KG
Kristie Grebe
Executive officer
ST
Stephen Thomas
Co-Founder and CEO, Sera Medicine, director
MV
Mathias Vinther
Director
SF
Scott Forrest
Chief Financial Officer
TB
Tausif Butt
CEO and President, director
KF
Khurem Farooq
Board Chair